ConductScience.org, home

Paper31389294

Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation.

Lyall MJ and 6 others. Epigenetics, 2020. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation. Papers, record 31389294. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31389294

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation.
PubMed
Journal
Epigenetics
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2025-05-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lyall MJMarcus Jhttps://orcid.org/0000-0002-2952-2676
2Thomson JPJohn P
3Cartier JJessy
4Ottaviano RRaffaele
5Kendall TJTimothy Jhttps://orcid.org/0000-0002-4174-2786
6Meehan RRRichard R
7Drake AJAmanda J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA MethylationMajor topic
Non-alcoholic Fatty Liver DiseaseMajor topic
5-Methylcytosine
Animals
Diet, High-Fat
Liver
Male
Mice
Mice, Inbred C57BL
Phenotype
Transcriptome

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
British Heart FoundationUnited KingdomPubMed
095898/Z/11/ZWellcome TrustUnited KingdomPubMed
MC_PC_U127574433Medical Research CouncilUnited KingdomPubMed
102839/Z/13/ZWellcome TrustUnited KingdomPubMed
Wellcome TrustUnited KingdomPubMed
MC_UU_00007/17Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120858492Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.Gastroenterology2011https://conductscience.org/library/papers/20858492PubMed
226707365Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Hepatology2016https://conductscience.org/library/papers/26707365PubMed
315915461Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology2005https://conductscience.org/library/papers/15915461PubMed
423598998Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver.Nucleic Acids Res2013https://conductscience.org/library/papers/23598998PubMed
529505975DNA methylation as a genomic marker of exposure to chemical and environmental agents.Curr Opin Chem Biol2018https://conductscience.org/library/papers/29505975PubMed
620639862Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.Nature2010https://conductscience.org/library/papers/20639862PubMed
722106369Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes.Genome Res2012https://conductscience.org/library/papers/22106369PubMed
828593184Epigenetics and Liver Fibrosis.Cell Mol Gastroenterol Hepatol2017https://conductscience.org/library/papers/28593184PubMed
929786565Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells.Philos Trans R Soc Lond B Biol Sci2018https://conductscience.org/library/papers/29786565PubMed
10288201765-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.Cell Res2017https://conductscience.org/library/papers/28820176PubMed
1125859289Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease.Clin Epigenetics2015https://conductscience.org/library/papers/25859289PubMed
12254118825-Hydroxymethylcytosine is a predominantly stable DNA modification.Nat Chem2014https://conductscience.org/library/papers/25411882PubMed
1325985418DNA immunoprecipitation semiconductor sequencing (DIP-SC-seq) as a rapid method to generate genome wide epigenetic signatures.Sci Rep2015https://conductscience.org/library/papers/25985418PubMed
1420569209Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA.Biotechniques2010https://conductscience.org/library/papers/20569209PubMed
1520126651The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing.PLoS One2010https://conductscience.org/library/papers/20126651PubMed
1621478462Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Diabetes Care2011https://conductscience.org/library/papers/21478462PubMed
1725632192Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.World J Gastroenterol2015https://conductscience.org/library/papers/25632192PubMed
1815561913The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.Diabetes2004https://conductscience.org/library/papers/15561913PubMed
1912029634Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.Hepatology2002https://conductscience.org/library/papers/12029634PubMed
2027002005Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.Gut2017https://conductscience.org/library/papers/27002005PubMed

See all 40 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
39941038Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD).Int J Mol Sci2025https://conductscience.org/library/papers/39941038PubMed
39861421A Guinea Pig Model of Pediatric Metabolic Dysfunction-Associated Steatohepatitis: Poor Vitamin C Status May Advance Disease.Nutrients2025https://conductscience.org/library/papers/39861421PubMed
39086681Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD).Front Mol Med2023https://conductscience.org/library/papers/39086681PubMed
37629043Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.Int J Mol Sci2023https://conductscience.org/library/papers/37629043PubMed
37231414
Obesity and dyslipidemia are associated with partially reversible modifications to DNA hydroxymethylation of apoptosis- and senescence-related genes in swine adipose-derived mesenchymal stem/stromal cells.
Stem Cell Res Ther2023https://conductscience.org/library/papers/37231414PubMed
37174674Metabolic Syndrome Induces Epigenetic Alterations in Mitochondria-Related Genes in Swine Mesenchymal Stem Cells.Cells2023https://conductscience.org/library/papers/37174674PubMed
36859394Genome-wide hydroxymethylation profiles in liver of female Nile tilapia with distinct growth performance.Sci Data2023https://conductscience.org/library/papers/36859394PubMed
36737504Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence.Hepatol Int2023https://conductscience.org/library/papers/36737504PubMed
36609599Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis.Exp Mol Med2023https://conductscience.org/library/papers/36609599PubMed
36435860Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.Cell Death Dis2022https://conductscience.org/library/papers/36435860PubMed
36299516Deciphering the role of aberrant DNA methylation in NAFLD and NASH.Heliyon2022https://conductscience.org/library/papers/36299516PubMed
35845591Mulberry Leaf Flavonoids Inhibit Liver Inflammation in Type 2 Diabetes Rats by Regulating TLR4/MyD88/NF-κB Signaling Pathway.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35845591PubMed
35723298DNA Methylation Patterns According to Fatty Liver Index and Longitudinal Changes from the Korean Genome and Epidemiology Study (KoGES).Curr Issues Mol Biol2022https://conductscience.org/library/papers/35723298PubMed
35038770Epigenetics provides a bridge between early nutrition and long-term health and a target for disease prevention.Acta Paediatr2022https://conductscience.org/library/papers/35038770PubMed
34572442Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.Biomedicines2021https://conductscience.org/library/papers/34572442PubMed
34335686The Co-occurrence of Chronic Hepatitis B and Fibrosis Is Associated With a Decrease in Hepatic Global DNA Methylation Levels in Patients With Non-alcoholic Fatty Liver Disease.Front Genet2021https://conductscience.org/library/papers/34335686PubMed
33918878Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions.Int J Mol Sci2021https://conductscience.org/library/papers/33918878PubMed
33836495Obesity is associated with heavy menstruation that may be due to delayed endometrial repair.J Endocrinol2021https://conductscience.org/library/papers/33836495PubMed
33810566Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity.Int J Mol Sci2021https://conductscience.org/library/papers/33810566PubMed
33567710Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date.Int J Environ Res Public Health2021https://conductscience.org/library/papers/33567710PubMed

See all 25 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IGFBP23485PubTator's text mininghttps://conductscience.org/library/genes/3485

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31389294

GET https://conductscience.org/api/papers/v1/31389294/references?page=2